Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Cerovive failure another blow for AstraZeneca

October 26, 2006 Research and Development, Sales and Marketing AstraZeneca, Cerovive, neuroscience

 A drug which had held out the promise of reducing the disabling effects of stroke on patients will be abandoned …
News

EU recommends first ever therapy for Hunter syndrome

October 24, 2006 Sales and Marketing

Shire has received full EU recommendation for the use of Elaprase for the long-term treatment of patients with Hunter syndrome.Marketing …
News

Industry calls for global healthcare systems to be benchmarked

October 13, 2006 Sales and Marketing

Fred Hassan, chief executive of Schering-Plough and new head of an international pharma industry organisation, has called for greater transparency …
News

New schizophrenia treatment promises no weight gain side-effects

October 13, 2006 Sales and Marketing

Solvay and Wyeth have filed a new treatment for schizophrenia with the US regulators, which promises to be free of …
News

From surgery to pharmacy

October 12, 2006 Sales and Marketing P, POM, marketing, reclassification, sales

Feature

Alzheimer’s drug ruling ”a terrible decision”

October 11, 2006 Sales and Marketing

Campaigners are stunned at NICE's final decision not to allow Alzheimer's drugs to be prescribed on the NHS in the …
News

Amgen to acquire Avidia

October 5, 2006 Research and Development, Sales and Marketing

Amgen is to pay $290 million to buy Avidia, a Californian biotech company which is developing innovative new protein-based medicines.Based …
News

Transparently beneficial?

October 2, 2006 Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma

The pharma industry is under greater pressure than ever before to adopt an acceptable and ethical way of doing business, …
Feature

Novartis submits next generation blood pressure drug

September 29, 2006 Sales and Marketing

Next generation hypertension drug Rasilez has been submitted for EU approval.If approved, Rasilez will be the first ever renin inhibitor, …
News

Three innovative medicines win Prix Galien awards

September 27, 2006 Sales and Marketing prix galien

Three pharmaceutical products have been awarded prizes at this year’s UK Prix Galien awards, which recognise excellence in pharmaceutical development …
News

UCB to buy Schwarz Pharma for 4 billion euros

September 26, 2006 Sales and Marketing

Belgian pharma company UCB is to buy Germany's Schwarz Pharma for 4.4 billion euros, creating a new mid-sized group with …
News

Noxafil close to approval for invasive fungal infections

September 25, 2006 Sales and Marketing

Schering-Plough's Noxafil is set to gain European approval for patients at high risk of developing invasive fungal infections.These infections can …
News

GSK gambles on success of new European pricing deal

September 25, 2006 Sales and Marketing EU, GSK

GlaxoSmithKline has unveiled a new deal which could break the deadlock over the pricing of medicines in Europe.The groundbreaking agreement …
News

Gardasil approved in Europe

September 22, 2006 Sales and Marketing Gardasil

Sanofi Pasteur MSD's Gardasil has been approved as the first ever vaccine to prevent women developing cervical cancer, which remains …
News

Specialist pharma company Nycomed buys Altana

September 22, 2006 Sales and Marketing Nycomed

Danish speciality pharmaceutical company Nycomed is to acquire pharma company Altana for 4.5 billion euros.Germany's Altana is currently a business …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026